U.S. markets close in 5 hours 32 minutes
  • S&P 500

    3,859.84
    +7.99 (+0.21%)
     
  • Dow 30

    31,259.35
    +70.97 (+0.23%)
     
  • Nasdaq

    13,513.42
    +56.17 (+0.42%)
     
  • Russell 2000

    2,148.04
    -12.58 (-0.58%)
     
  • Crude Oil

    53.10
    -0.21 (-0.39%)
     
  • Gold

    1,866.00
    -0.50 (-0.03%)
     
  • Silver

    25.85
    +0.08 (+0.33%)
     
  • EUR/USD

    1.2171
    +0.0056 (+0.46%)
     
  • 10-Yr Bond

    1.1130
    +0.0230 (+2.11%)
     
  • GBP/USD

    1.3735
    +0.0080 (+0.59%)
     
  • USD/JPY

    103.4760
    -0.0940 (-0.09%)
     
  • BTC-USD

    31,776.57
    -1,725.52 (-5.15%)
     
  • CMC Crypto 200

    632.28
    -47.62 (-7.00%)
     
  • FTSE 100

    6,725.49
    -14.90 (-0.22%)
     
  • Nikkei 225

    28,756.86
    +233.60 (+0.82%)
     

Atomera Provides Second Quarter 2020 Results

Atomera Incorporated
·7 min read

LOS GATOS, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the second quarter ended June 30, 2020.

Company Highlights

  • Grew to a record 17 customer engagements in Phase 3

  • Validated Atomera’s breakthrough MST-SP results on customer silicon

  • Completed $10 million public offering of common stock

Management Commentary

“We are very pleased to continue making significant technical progress toward license agreements with large semiconductor manufacturers. Despite some minor slowdowns due to the pandemic, we have strengthened our overall pipeline by adding a 17th customer engagement to the critical Phase 3 of our engagement cycle,” said Scott Bibaud, President and CEO. “With recent promising results of our MST-SP technology on customer silicon, we are increasingly optimistic that adoption in 5 volt power and analog chips is closer than ever.”

Second Quarter 2020 Financial Results

During the second quarter of 2020, revenue was $0, compared with $70,000 in the second quarter of 2019. The Company incurred a net loss of $3.8 million, or ($0.21) per basic and diluted share, in the second quarter of 2020, compared to a net loss of $3.6 million, or ($0.24) per basic and diluted share, for the second quarter of 2019. Adjusted EBITDA (a non-GAAP financial measure) in the second quarter of 2020 was a loss of $3.0 million compared to an adjusted EBITDA loss of $2.9 million in the second quarter of 2019.

The Company had $18.0 million in cash and cash equivalents as of June 30, 2020, compared to $14.9 million as of December 31, 2019.

The total number of shares outstanding was 19.8 million as of June 30, 2020.

Second Quarter 2020 Results Conference Call and Webcast

Atomera will host a conference call today to discuss its financial results and recent progress.
Date: Wednesday, Aug. 5, 2020
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at www.atomera.com
Phone: (844) 263-8318 (domestic); +1 (213) 358­-0960 (international)
Replay: Available until August 12, 2020; (855) 859­2056 (domestic); +1(404) 537-­3406 (international); passcode 921-6988.

Note about Non-­GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-­GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock­-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly­-titled measures used by other companies. We believe that this non­-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated has developed Mears Silicon Technology™ ("MST®"), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano­scaling technologies already in the semiconductor industry roadmap.

Safe Harbor

This press release contains forward-­looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-­looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations or entered into a definitive royalty-based manufacturing and distribution license agreement with regard to our MST technology, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) risks related to our ability to advance the licensing arrangements with our initial integration licensees, Asahi Kasei Microdevices, ST Microelectronics and our fabless licensee, to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (3) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (4) impact of the coronavirus pandemic on our customers, partners, internal operations and market conditions, including our ability to access financial markets on favorable terms, (5) our ability to protect our proprietary technology, trade secrets and know-­how and (6) those other risks disclosed in the section "Risk Factors" included in our Prospectus Supplement filed pursuant to Rule 424(b)(5) with the SEC on May 13, 2020. We caution readers not to place undue reliance on any forward-­looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow --



Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)

June 30,

December 31,

2020

2019

(Unaudited)

ASSETS

Current assets:

Cash and cash equivalents

$

17,965

$

14,871

Prepaid expenses and other current assets

255

132

Total current assets

18,220

15,003

Property and equipment, net

53

63

Operating lease right-of-use asset

89

161

Long-term prepaid rent

450

Security deposit

13

13

Total assets

$

18,825

$

15,240

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$

586

$

315

Accrued expenses

178

145

Accrued payroll related expenses

405

819

Current operating lease liability

78

152

Deferred revenue

37

Total liabilities

1,247

1,468

Stockholders’ equity:

Preferred stock, $0.001 par value, authorized 2,500 shares; none issued and outstanding at June 30, 2020 and December 31, 2019.

Common stock, $0.001 par value, authorized 47,500 shares; 19,826 and 17,117 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively.

20

17

Additional paid-in capital

160,244

149,017

Accumulated deficit

(142,686

)

(135,262

)

Total stockholders’ equity

17,578

13,772

Total liabilities and stockholders’ equity

$

18,825

$

15,240



Atomera Incorporated
Condensed Statements of Operations
(Unaudited)
(in thousands, except per share data)

Three Months ended
June 30,

Six Months ended
June 30,

2020

2019

2020

2019

Revenue

$

$

70

$

62

$

141

Cost of revenue

(20

)

(13

)

(20

)

Gross margin

50

49

121

Operating expenses

Research and development

2,086

2,057

4,148

4.184

General and administrative

1,480

1,488

2,925

2,809

Selling and marketing

215

225

440

472

Total operating expenses

3,781

3,770

7,513

7,465

Loss from operations

(3,781

)

(3,720

)

(7,464

)

(7,344

)

Other income

Interest income

2

86

40

176

Total other income

2

86

40

176

Net loss

$

(3,779

)

$

(3,634

)

$

(7,424

)

$

(7,168

)

Net loss per common share, basic and diluted

$

(0.21

)

$

(0.24

)

$

(0.43

)

$

(0.47

)

Weighted average number of common shares outstanding, basic and diluted

17,975

15,423

17,367

15,104




Atomera Incorporated

Reconciliation to Non-GAAP EBITDA
(Unaudited)

Three Months Ended
June 30

Six Months Ended
June 30,

2020

2019

2020

2019

Net loss (GAAP)

$

(3,779

)

$

(3,634

)

$

(7,424

)

$

(7,168

)

Add (subtract) the following items:

Interest income

(2

)

(86

)

(40

)

(176

)

Depreciation and amortization

11

11

21

21

Warrant modification

139

Stock-based compensation

766

788

1,395

1,482

Adjusted EBITDA (non-GAAP)

$

(3,004

)

$

(2,921

)

$

(5,909

)

$

(5,841

)

Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com